Anagrelide is a phosphodiesterase inhibitor used clinically to reduce platelet counts in patients with essential thrombocythemia and chronic myeloid leukemia. This category includes a comprehensive range… Read more















![Chemical structure of 6,7-Dichloro-5-hydroxy-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F67-Dichloro-5-hydroxy-15-dihydroimidazo21-bquinazolin-23H-one.png&w=3840&q=75)






















![Chemical structure of Methyl 2-(4,5-dichloro-1,1a-dihydrodiazirino[1,3-a]quinazolin-2(3H)-yl)acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FMethyl-2-45-dichloro-11a-dihydrodiazirino13-aquinazolin-23H-ylacetate.png&w=3840&q=75)
Anagrelide is a phosphodiesterase inhibitor used clinically to reduce platelet counts in patients with essential thrombocythemia and chronic myeloid leukemia. This category includes a comprehensive range of high-quality reference standards essential for the precise analysis of this therapeutic agent. Pharmaceutical laboratories rely on these materials, including pharmacopeial and non-pharmacopeial impurities, degradation products, and stable isotope labelled compounds, to conduct rigorous quality control and method validation. By utilizing these characterized standards, researchers can accurately perform impurity profiling and stability studies in compliance with regulatory guidelines. Stable isotope labelled versions of the drug and its related compounds are particularly valuable for use as internal standards in mass spectrometry-based analytical methods. These materials support accurate monitoring of the drug’s purity and safety throughout the pharmaceutical development and manufacturing lifecycle.